BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,029 | +12.2% | 20,502 | +41.2% | 0.00% | 0.0% |
| Q2 2023 | $917 | +6953.8% | 14,524 | +4908.3% | 0.00% | – |
| Q1 2023 | $13 | -100.0% | 290 | -88.7% | 0.00% | – |
| Q1 2022 | $164,000 | +241.7% | 2,569 | +366.2% | 0.00% | – |
| Q3 2021 | $48,000 | 0.0% | 551 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | – | 551 | +8.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 508 | +408.0% | 0.00% | – |
| Q1 2020 | $5,000 | -96.9% | 100 | -95.5% | 0.00% | – |
| Q3 2019 | $161,000 | -43.3% | 2,198 | -51.0% | 0.00% | -100.0% |
| Q2 2018 | $284,000 | +195.8% | 4,484 | +249.2% | 0.00% | -75.0% |
| Q4 2017 | $96,000 | -41.5% | 1,284 | -68.7% | 0.00% | -42.9% |
| Q1 2017 | $164,000 | +1540.0% | 4,106 | +1009.7% | 0.01% | +600.0% |
| Q3 2016 | $10,000 | +900.0% | 370 | +386.8% | 0.00% | – |
| Q2 2016 | $1,000 | -96.3% | 76 | -92.6% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | +800.0% | 1,026 | +460.7% | 0.00% | – |
| Q3 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |